Cargando...
Advances in the treatment of soft tissue sarcoma: focus on eribulin
Eribulin mesylate is a synthetic derivative of halichondrin B isolated from a marine sponge. Its mechanism of action is through microtubule inhibition, which is different from that of taxanes. Eribulin has been approved for the treatment of metastatic breast cancer and more recently for non-operable...
Gardado en:
| Publicado en: | Cancer Manag Res |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Dove Medical Press
2018
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5798537/ https://ncbi.nlm.nih.gov/pubmed/29440930 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S143019 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|